{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:16:26Z","timestamp":1785928586163,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018550","name":"Lowy Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xops.2024.100618","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:25:07Z","timestamp":1726115107000},"page":"100618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characterization of the Retinal Phenotype Using Multimodal Imaging in Novel Compound Heterozygote Variants of CYP2U1"],"prefix":"10.1016","volume":"5","author":[{"given":"Ferenc B.","family":"Sallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Dysli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz Josef","family":"Holzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Ranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Guipponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos E.","family":"Antonarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis L.","family":"Munier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Schorderet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Rossillion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5050-5558","authenticated-orcid":false,"given":"Veronika","family":"Vaclavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2024.100618_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","article-title":"Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms","volume":"126","author":"Fink","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.xops.2024.100618_bib2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00439-015-1536-7","article-title":"Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology","volume":"134","author":"Tesson","year":"2015","journal-title":"Hum Genet"},{"key":"10.1016\/j.xops.2024.100618_bib3","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1074\/jbc.M311830200","article-title":"CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids","volume":"279","author":"Chuang","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xops.2024.100618_bib4","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210846","article-title":"Implication of folate deficiency in CYP2U1 loss of function","volume":"218","author":"Pujol","year":"2021","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.xops.2024.100618_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ajhg.2012.11.001","article-title":"Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia","volume":"91","author":"Tesson","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.xops.2024.100618_bib6","first-page":"373","article-title":"Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis","volume":"261","author":"Citterio","year":"2014","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.xops.2024.100618_bib7","first-page":"586","article-title":"Long-term follow-up in spastic paraplegia due to SPG56\/CYP2U1: age-dependency rather than genetic variability?","volume":"264","author":"Iodice","year":"2017","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.xops.2024.100618_bib8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejpn.2016.05.013","article-title":"CYP2U1 mutations in two Iranian patients with activity induced dystonia, motor regression and spastic paraplegia","volume":"20","author":"Kariminejad","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.xops.2024.100618_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10048-016-0495-z","article-title":"Defining the genetic basis of early onset hereditary spastic paraplegia using whole genome sequencing","volume":"17","author":"Kumar","year":"2016","journal-title":"Neurogenetics"},{"key":"10.1016\/j.xops.2024.100618_bib10","first-page":"781","article-title":"Pigmentary degenerative maculopathy as prominent phenotype in an Italian SPG56\/CYP2U1 family","volume":"263","author":"Leonardi","year":"2016","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.xops.2024.100618_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejpn.2016.02.001","article-title":"Hereditary spastic paraplegia: novel mutations and expansion of the phenotype variability in SPG56","volume":"20","author":"Masciullo","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.xops.2024.100618_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/humu.23359","article-title":"CYP2U1 activity is altered by missense mutations in hereditary spastic paraplegia 56","volume":"39","author":"Durand","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.xops.2024.100618_bib13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/jhg.2017.77","article-title":"An atypical case of SPG56\/CYP2U1-related spastic paraplegia presenting with delayed myelination","volume":"62","author":"Minase","year":"2017","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.xops.2024.100618_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/joim.13193","article-title":"Pseudoxanthoma elasticum overlaps hereditary spastic paraplegia type 56","volume":"289","author":"Legrand","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.xops.2024.100618_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","article-title":"Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms","volume":"261","author":"Lo Giudice","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.xops.2024.100618_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00417-022-05786-4","article-title":"Clinical-genetic findings in a group of subjects with macular dystrophies due to mutations in rare inherited retinopathy genes","volume":"261","author":"Zenteno","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2024.100618_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","article-title":"Macular telangiectasia type 2","volume":"34","author":"Charbel Issa","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2024.100618_bib18","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(93)31447-8","article-title":"Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study","volume":"100","author":"Gass","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100618_bib19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaophthalmol.2018.3283","article-title":"Genetic penetrance of macular telangiectasia type 2","volume":"136","author":"Ronquillo","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2024.100618_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024268","article-title":"Identification of a potential susceptibility locus for macular telangiectasia type 2","volume":"7","author":"Parmalee","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.xops.2024.100618_bib21","first-page":"2718","article-title":"Analysis of candidate genes for macular telangiectasia type 2","volume":"16","author":"Parmalee","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/j.xops.2024.100618_bib22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ng.3799","article-title":"Genome-wide analyses identify common variants associated with macular telangiectasia type 2","volume":"49","author":"Scerri","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.xops.2024.100618_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.xops.2024.100618_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.preteyeres.2017.06.005","article-title":"Fluorescence lifetime imaging ophthalmoscopy","volume":"60","author":"Dysli","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2024.100618_bib25","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1167\/iovs.13-13627","article-title":"Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects","volume":"55","author":"Dysli","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2024.100618_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2018.09.041","article-title":"Effect of ciliary neurotrophic factor on retinal neurodegeneration in patients with macular telangiectasia type 2: a randomized clinical trial","volume":"126","author":"Chew","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100618_bib27","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1167\/iovs.12-10580","article-title":"\u201cEn face\u201d OCT imaging of the IS\/OS junction line in type 2 idiopathic macular telangiectasia","volume":"53","author":"Sallo","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2024.100618_bib28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/IAE.0b013e318196bd65","article-title":"Fixation stability measurement using the MP1 microperimeter","volume":"29","author":"Crossland","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100618_bib29","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","article-title":"Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy","volume":"135","author":"Klebe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.xops.2024.100618_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116620","article-title":"Ophthalmological changes in hereditary spastic paraplegia and other genetic diseases with spastic paraplegia","volume":"409","author":"de Freitas","year":"2020","journal-title":"J\u00a0Neurol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.xops.2024.100618_bib31","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/IAE.0000000000001728","article-title":"Abnormal retinal reflectivity to short-wavelength light in type 2 idiopathic macular telangiectasia","volume":"38","author":"Sallo","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100618_bib32","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1167\/iovs.07-0636","article-title":"Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia","volume":"49","author":"Charbel","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2024.100618_bib33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ophtha.2020.03.040","article-title":"Macular telangiectasia type 2: visual acuity, disease end stage, and the MacTel Area: MacTel Project Report Number 8","volume":"127","author":"Heeren","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100618_bib34","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1111\/aos.14110","article-title":"Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2","volume":"97","author":"Pauleikhoff","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2024.100618_bib35","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ophtha.2009.10.019","article-title":"Patients with Sj\u00f6gren-Larsson syndrome lack macular pigment","volume":"117","author":"van der Veen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100618_bib36","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1167\/iovs.18-23886","article-title":"Fluorescence lifetime imaging ophthalmoscopy (FLIO) of macular pigment","volume":"59","author":"Sauer","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2024.100618_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.oret.2017.10.008","article-title":"Fluorescence lifetime imaging ophthalmoscopy: a novel way to assess macular telangiectasia type 2","volume":"2","author":"Sauer","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2024.100618_bib38","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1097\/IAE.0000000000001452","article-title":"Fundus autofluorescence lifetimes and central serous chorioretinopathy","volume":"37","author":"Dysli","year":"2017","journal-title":"Retina"},{"issue":"Suppl 1","key":"10.1016\/j.xops.2024.100618_bib39","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/IAE.0000000000001842","article-title":"Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia","volume":"38","author":"Leung","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100618_bib40","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1167\/iovs.12-10765","article-title":"The IS\/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia","volume":"53","author":"Sallo","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2024.100618_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jamaophthalmol.2015.1796","article-title":"Macular telangiectasia type 2 without clinically detectable vasculopathy","volume":"133","author":"Gillies","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2024.100618_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s42255-021-00361-3","article-title":"Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease","volume":"3","author":"Eade","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.xops.2024.100618_bib43","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1815111","article-title":"Serine and lipid metabolism in macular disease and peripheral neuropathy","volume":"381","author":"Gantner","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xops.2024.100618_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-021-00848-4","article-title":"Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression","volume":"13","author":"Bonelli","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.xops.2024.100618_bib45","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1074\/jbc.M109.092973","article-title":"Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids","volume":"285","author":"Penno","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xops.2024.100618_bib46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajhg.2010.09.010","article-title":"Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I","volume":"87","author":"Rotthier","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.xops.2024.100618_bib47","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1074\/jbc.R115.658823","article-title":"1-Deoxysphingolipids encountered exogenously and made de novo: dangerous mysteries inside an enigma","volume":"290","author":"Duan","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xops.2024.100618_bib48","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41467-019-09253-3","article-title":"Coming together to define membrane contact sites","volume":"10","author":"Scorrano","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.xops.2024.100618_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.oret.2021.02.017","article-title":"Mitochondrial retinopathy","volume":"6","author":"Birtel","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2024.100618_bib50","doi-asserted-by":"crossref","first-page":"18780","DOI":"10.1073\/pnas.2011532117","article-title":"A\u00a0connectomics approach to understanding a retinal disease","volume":"117","author":"Zucker","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2024.100618_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1194\/jlr.M068676","article-title":"Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction","volume":"58","author":"Alecu","year":"2017","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.xops.2024.100618_bib52","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1007\/s12035-017-0840-8","article-title":"Disruption of de novo serine synthesis in M\u00fcller cells induced mitochondrial dysfunction and aggravated oxidative damage","volume":"55","author":"Zhang","year":"2018","journal-title":"Mol Neurobiol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524001544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524001544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:45:17Z","timestamp":1772048717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914524001544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2666914524001544"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2024.100618","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the Retinal Phenotype Using Multimodal Imaging in Novel Compound Heterozygote Variants of CYP2U1","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2024.100618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100618"}}